Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
MEDI4736 + Olaparib for Advanced Cancers
Recruiting3 awardsPhase 1 & 2
Newnan, Georgia
This trial is testing a new cancer drug combination to see if it is effective, safe, and has anti-tumor activity. The study will also look at how the drugs are metabolized and how well the combination is tolerated.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.